Komori
Disclosure2160GNI Group Ltd.Pharmaceuticals

From the Growth Market to TOPIX: GNI Group Ltd. newly added in the first regular index reshuffle following the system reforms

GNI Group shares will be newly added as a TOPIX constituent. They are scheduled to be included in the index from 30 October 2026, making this a case of a Growth Market-listed company being selected for inclusion in TOPIX.

Worth reading
71In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
140
¥ trillion (assets managed in line with TOPIX)
Wording
Conditional
How definitive the wording is.

Decision and Details

Selection as a TOPIX (Tokyo Stock Price Index) constituent

Decision7 October 2026 (disclosure date; Not disclosed as the selection decision date)
ImplementationFrom 30 October 2026 (scheduled)
Going forwardScheduled to be included as a TOPIX constituent from 30 October 2026.
AmountApproximately ¥140 trillion (assets managed in line with TOPIX)
Quantity / scaleNew selection as a TOPIX constituent; selection from the Growth Market
Reason

Because the TOPIX reforms introduced scheduled rebalancing covering all market segments, based on criteria including liquidity and free-float market capitalisation.

Impact on Business Performance

The specific impact on earnings is Not disclosed. The company expects its shareholder base to diversify and stabilise, and investment and research opportunities and its profile to improve.

Decision and Details
ItemDetails
Matter CoveredSelection as a TOPIX (Tokyo Stock Price Index) constituent
Decision Date7 October 2026 (disclosure date; Not disclosed as the selection decision date)
Implementation DateFrom 30 October 2026 (scheduled)
AmountApproximately ¥140 trillion (assets managed in line with TOPIX)
Quantity / scaleNew selection as a TOPIX constituent; selection from the Growth Market
Impact on Business PerformanceThe specific impact on earnings is Not disclosed. The company expects its shareholder base to diversify and stabilise, and investment and research opportunities and its profile to improve.
ReasonBecause the TOPIX reforms introduced scheduled rebalancing covering all market segments, based on criteria including liquidity and free-float market capitalisation.
Governing RuleScheduled rebalancing under the second-stage TOPIX review (specific timely disclosure rules and statutory provisions are Not disclosed)
Future plansScheduled to be included as a TOPIX constituent from 30 October 2026.
Items this document does not state (3)
Decision-Making BodyPeriod CoveredRelated previous disclosures

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The TOPIX system reforms introduced scheduled rebalancing covering all market segments: Prime, Standard and Growth. GNI Group was selected based on criteria including liquidity and free-float market capitalisation. The company expects the selection to diversify and stabilise its shareholder base, expand investment and research opportunities for institutional investors, and raise its profile in the capital markets.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
From the Growth Market to TOPIX: GNI Group Ltd. newly added in the first regular index reshuffle following the system reforms | GNI Group Ltd. (2160) timely disclosure | Komori